A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 493.42
C 33.08
GOOG 606.73
BAC 8.06
RIMM 15.60

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.65

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
31.72 -0.27 (-0.85%) BMY

Click Here to Receive Instant E-mail and RSS Alerts


Trade BMY now with

Stock Details

Last Trade:31.72 Change:-0.27 (-0.85%) Prev Close:31.99 Open: 31.75 Days Range:31.66 – 31.82 52 Week Range: 24.97 - 35.44 Volume:494747 P/E: 14.69
EPS:2.16





Recent Blog Posts

Blog Posts on 02/10/12 at 2:58am
Quantifying The Diminishing Impact Of QE On Stocks
Blog Posts on 02/09/12 at 7:13am
5 Pharmaceutical Stocks To Consider Now
Blog Posts on 02/09/12 at 4:22am
Beating The Market Is Harder Than You Think
Blog Posts on 02/08/12 at 11:46am
Medgenics' Disruptive Biotechnology Is One To Watch
Blog Posts on 02/07/12 at 7:23pm
Big Pharma's Potential Consumer Growth Avenue
Blog Posts on 02/07/12 at 3:10pm
Big, Robust Pipelines At Small Biotech Companies
Blog Posts on 02/07/12 at 10:46am
IPO Preview: ChemoCentryx
Blog Posts on 02/07/12 at 10:06am
Trading Biotech In Pairs: A Better Way To Hedge
Blog Posts on 02/07/12 at 9:25am
5 High-Yield Stocks To Consider Now
Blog Posts on 02/06/12 at 1:09pm
Big Money Potential In Chelsea Therapeutics
Blog Posts on 02/06/12 at 8:44am
2 Biotechs On Teva's Radar Screen
Blog Posts on 02/05/12 at 4:56am
3 M&A Arbitrage Opportunities
Blog Posts on 02/03/12 at 6:27pm
5 Crisis-Proof Stocks That Outperform The Market
Blog Posts on 02/03/12 at 4:34pm
6 Ways To Trade A Robust Employment Report
Blog Posts on 02/03/12 at 2:53pm
Merck Looks Like A Name To Own In Drugs
Blog Posts on 02/03/12 at 11:31am
6 Stable Dividend Stocks That Will Beat Bonds
Blog Posts on 02/02/12 at 10:25am
Antares's Promising New RA Treatment Method Revisited
Blog Posts on 02/02/12 at 5:52am
Roche's Earnings Show Real Progress
Blog Posts on 02/01/12 at 8:38am
What Is A Moat?
Blog Posts on 02/01/12 at 7:40am
5 Solid Free Cash Flow Generators
Blog Posts on 02/01/12 at 7:38am
Sanofi More Undervalued Than Bristol, Pfizer